Digestive Diseases and Sciences

, Volume 57, Issue 9, pp 2408–2415 | Cite as

Geriatric Inflammatory Bowel Disease: Phenotypic Presentation, Treatment Patterns, Nutritional Status, Outcomes, and Comorbidity

  • Manie Juneja
  • Leonard Baidoo
  • Marc B. Schwartz
  • Arthur BarrieIII
  • Miguel Regueiro
  • Michael Dunn
  • David G. Binion
Original Article

Abstract

Background and Aims

The U.S. population is aging and the burden of geriatric inflammatory bowel disease (IBD) patients has increased. Systematic data describing phenotypic presentation, treatment regimens, outcomes and comorbidities in elderly IBD patients is limited. We performed a retrospective observational study of IBD patients age ≥65 followed in a 20-hospital system to determine patterns of phenotypic presentation, treatment, polypharmacy, nutritional status and comorbidity.

Methods

Data were extracted from electronic medical record based on ICD-9 coding/indexed terms on Crohn’s disease (CD) and ulcerative colitis (UC) patients.

Results

A total of 393 geriatric IBD patients were identified (49.1% males; 50.9% females; 61.8% UC; 38.2% CD; 73.4 ± 6.6 years old). Younger age at diagnosis of CD (≤64) was associated with greater prevalence of small bowel surgeries (63.6%) compared with those diagnosed after age ≥65 (20.9%) (p < 0.005). Fistulizing/penetrating disease was frequent in patients diagnosed with CD at a younger age (43.6% compared to 7%) (p < 0.005). IBD maintenance treatment included: 44% 5-ASA agents; 31.6% maintenance prednisone (defined as ≥6 months treatment duration); 4.8% steroid suppositories; 5.6% 6MP/azathioprine; 1.3% methotrexate; 1.3% adalimumab; 1.3% infliximab; 9.4% loperamide/diphenoxylate/atropine; 0.5% had no IBD medications. Longer duration of CD disease correlated with vitamin B12, vitamin D and iron deficiency.

Conclusion

Geriatric patients diagnosed with CD earlier in life had greater small bowel involvement compared with new onset geriatric CD. There is low utilization of immunomodulator and biologic agents in geriatric IBD patients. Duration of CD correlates with nutrient deficiency. Prospective studies are warranted in this respect.

Keywords

Inflammatory bowel disease Geriatric Elderly Aging Nutrition Immune modulators Polypharmacy Malnutrition Vitamin B12 Vitamin D 

References

  1. 1.
    Yount RJ, Vries JK, Councill CD. The medical archival system: an information retrieval system based on distributed parallel processing. Inf Proc Manag. 1991;27:379–389.CrossRefGoogle Scholar
  2. 2.
    Ananthakrishnan AN, McGinley EL, Binion DG. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2009;15:182–189.PubMedCrossRefGoogle Scholar
  3. 3.
    Heresbach D, Alexandre JL, Bretagne JF, et al. Crohn’s disease in the over-60 age group: a population based study. Eur J Gastroenterol Hepatol. 2004;16:657–664.PubMedCrossRefGoogle Scholar
  4. 4.
    Page MJ, Poritz LS, Kunselman SJ, Koltun WA. Factors affecting surgical risk in elderly patients with inflammatory bowel disease. J Gastrointest Surg. 2002;6:606–613.PubMedCrossRefGoogle Scholar
  5. 5.
    Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075–1079; discussion 1081–1090.Google Scholar
  6. 6.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.PubMedCrossRefGoogle Scholar
  7. 7.
    Cook JD. Clinical evaluation of iron deficiency. Semin Hematol. 1982;19:6–18.PubMedGoogle Scholar
  8. 8.
    Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. Clin Interv Aging. 2008;3:383–389.PubMedGoogle Scholar
  9. 9.
    Tal S, Shavit Y, Stern F, Malnick S. Association between vitamin B12 levels and mortality in hospitalized older adults. J Am Geriatr Soc. 2010;58:523–526.PubMedCrossRefGoogle Scholar
  10. 10.
    Wilhelm-Leen ER, Hall YN, Deboer IH, Chertow GM. Vitamin D deficiency and frailty in older Americans. J Intern Med. 2010;268:171–180.PubMedCrossRefGoogle Scholar
  11. 11.
    Gassull MA, Cabre E. Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2001;4:561–569.PubMedCrossRefGoogle Scholar
  12. 12.
    Headstrom PD, Rulyak SJ, Lee SD. Prevalence of and risk factors for vitamin B(12) deficiency in patients with Crohn’s disease. Inflamm Bowel Dis. 2008;14:217–223.PubMedCrossRefGoogle Scholar
  13. 13.
    Siffledeen JS, Siminoski K, Steinhart H, Greenberg G, Fedorak RN. The frequency of vitamin D deficiency in adults with Crohn’s disease. Can J Gastroenterol. 2003;17:473–478.PubMedGoogle Scholar
  14. 14.
    Tajika M, Matsuura A, Nakamura T, et al. Risk factors for vitamin D deficiency in patients with Crohn’s disease. J Gastroenterol. 2004;39:527–533.PubMedCrossRefGoogle Scholar
  15. 15.
    Thomson AB, Brust R, Ali MA, Mant MJ, Valberg LS. Iron deficiency in inflammatory bowel disease. Diagnostic efficacy of serum ferritin. Am J Dig Dis. 1978;23:705–709.PubMedCrossRefGoogle Scholar
  16. 16.
    Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin d status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:192–199.PubMedCrossRefGoogle Scholar
  17. 17.
    Feagan BG, Vreeland MG, Larson LR, Bala MV. Annual cost of care for Crohn’s disease: a payor perspective. Am J Gastroenterol. 2000;95:1955–1960.PubMedCrossRefGoogle Scholar
  18. 18.
    Robertson DJ, Grimm IS. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 2001;30:409–426.PubMedCrossRefGoogle Scholar
  19. 19.
    Russel MG, Stockbrugger RW. Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol. 1996;31:417–427.PubMedCrossRefGoogle Scholar
  20. 20.
    Softley A, Myren J, Clamp SE, Bouchier IA, Watkinson G, de Dombal FT. Inflammatory bowel disease in the elderly patient. Scand J Gastroenterol Suppl. 1988;144:27–30.PubMedGoogle Scholar
  21. 21.
    Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gut 2000;46:336–343.Google Scholar
  22. 22.
    Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:2272–2280.PubMedCrossRefGoogle Scholar
  23. 23.
    Surjan G. Questions on validity of international classification of diseases-coded diagnoses. Int J Med Inform. 1999;54:77–95.PubMedCrossRefGoogle Scholar
  24. 24.
    Longobardi T, Bernstein CN. Health care resource utilization in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:731–743.PubMedCrossRefGoogle Scholar
  25. 25.
    Grimm IS, Friedman LS. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 1990;19:361–389.PubMedGoogle Scholar
  26. 26.
    Maini R, St Clair EW, Breedveld F, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Attract study group. Lancet 1999;354:1932–1939.Google Scholar
  27. 27.
    Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med. 1989;111:641–649.PubMedGoogle Scholar
  28. 28.
    O’Brien JJ, Bayless TM, Bayless JA. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn’s disease. Gastroenterology. 1991;101:39–46.PubMedGoogle Scholar
  29. 29.
    Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300:2867–2878.PubMedCrossRefGoogle Scholar
  30. 30.
    Gee MI, Grace MG, Wensel RH, Sherbaniuk R, Thomson AB. Protein-energy malnutrition in gastroenterology outpatients: increased risk in Crohn’s disease. J Am Diet Assoc. 1985;85:1466–1474.PubMedGoogle Scholar
  31. 31.
    Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr. 1998;67:919–926.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Manie Juneja
    • 1
  • Leonard Baidoo
    • 2
  • Marc B. Schwartz
    • 2
  • Arthur BarrieIII
    • 2
  • Miguel Regueiro
    • 2
  • Michael Dunn
    • 2
  • David G. Binion
    • 2
  1. 1.Department of MedicineGeorgetown University School of MedicineWashingtonUSA
  2. 2.Division of Gastroenterology, Hepatology and NutritionUniversity of Pittsburgh School of MedicinePittsburghUSA

Personalised recommendations